210 related articles for article (PubMed ID: 32275465)
1. Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus.
Wolfe DN; Taylor MJ; Zarrabian AG
Hum Vaccin Immunother; 2020 Nov; 16(11):2855-2860. PubMed ID: 32275465
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
Lehrer AT; Chuang E; Namekar M; Williams CA; Wong TAS; Lieberman MM; Granados A; Misamore J; Yalley-Ogunro J; Andersen H; Geisbert JB; Agans KN; Cross RW; Geisbert TW
Front Immunol; 2021; 12():703986. PubMed ID: 34484200
[TBL] [Abstract][Full Text] [Related]
3. [Ebola and Marburg hemorrhagic fever viruses: update on filoviruses].
Leroy E; Baize S; Gonzalez JP
Med Trop (Mars); 2011 Apr; 71(2):111-21. PubMed ID: 21695865
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of Filoviridae: Marburg and Ebola viruses.
Beer B; Kurth R; Bukreyev A
Naturwissenschaften; 1999 Jan; 86(1):8-17. PubMed ID: 10024977
[TBL] [Abstract][Full Text] [Related]
5. Sequencing ebola and marburg viruses genomes using microarrays.
Hardick J; Woelfel R; Gardner W; Ibrahim S
J Med Virol; 2016 Aug; 88(8):1303-8. PubMed ID: 26822839
[TBL] [Abstract][Full Text] [Related]
6. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
[TBL] [Abstract][Full Text] [Related]
7. Filoviruses: Scientific Gaps and Prototype Pathogen Recommendation.
Dupuy LC; Spiropoulou CF; Towner JS; Spengler JR; Sullivan NJ; Montgomery JM
J Infect Dis; 2023 Oct; 228(Suppl 6):S446-S459. PubMed ID: 37849404
[TBL] [Abstract][Full Text] [Related]
8. Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infection.
To A; Wong TAS; Ball AH; Lieberman MM; Yalley-Ogunro J; Cabus M; Nezami S; Paz F; Elyard HA; Borisevich V; Agans KN; Deer DJ; Woolsey C; Cross RW; Geisbert TW; Donini O; Lehrer AT
Vaccine; 2024 Jan; 42(3):598-607. PubMed ID: 38158300
[TBL] [Abstract][Full Text] [Related]
9. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
10. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.
Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ
J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533
[TBL] [Abstract][Full Text] [Related]
11. [Marburg and Ebola hemorrhagic fevers--pathogens, epidemiology and therapy].
Stock I
Med Monatsschr Pharm; 2014 Sep; 37(9):324-30; quiz 331-2. PubMed ID: 25282746
[TBL] [Abstract][Full Text] [Related]
12. Development, validation and clinical evaluation of a broad-range pan-filovirus RT-qPCR.
Jääskeläinen AJ; Sironen T; Diagne CT; Diagne MM; Faye M; Faye O; Faye O; Hewson R; Mölsä M; Weidmann MW; Watson R; Sall AA; Vapalahti O
J Clin Virol; 2019 May; 114():26-31. PubMed ID: 30904708
[TBL] [Abstract][Full Text] [Related]
13. Approaches to demonstrating the effectiveness of filovirus vaccines: Lessons from Ebola and COVID-19.
Gruber MF; Rubin S; Krause PR
Front Immunol; 2023; 14():1109486. PubMed ID: 36817425
[TBL] [Abstract][Full Text] [Related]
14. Geographic potential of disease caused by Ebola and Marburg viruses in Africa.
Peterson AT; Samy AM
Acta Trop; 2016 Oct; 162():114-124. PubMed ID: 27311387
[TBL] [Abstract][Full Text] [Related]
15. Catching Chances: The Movement to Be on the Ground and Research Ready before an Outbreak.
Brett-Major D; Lawler J
Viruses; 2018 Aug; 10(8):. PubMed ID: 30126221
[TBL] [Abstract][Full Text] [Related]
16. Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.
Suschak JJ; Schmaljohn CS
Hum Vaccin Immunother; 2019; 15(10):2359-2377. PubMed ID: 31589088
[TBL] [Abstract][Full Text] [Related]
17. Setting-up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned.
Zola Matuvanga T; Larivière Y; Lemey G; De Bie J; Milolo S; Meta R; Esanga E; Vermeiren PP; Thys S; Van Geertruyden JP; Van Damme P; Maketa V; Matangila J; Mitashi P; Muhindo-Mavoko H
Vaccine; 2022 May; 40(25):3470-3480. PubMed ID: 35550847
[TBL] [Abstract][Full Text] [Related]
18. Rapid Confirmation of the Zaire Ebola Virus in the Outbreak of the Equateur Province in the Democratic Republic of Congo: Implications for Public Health Interventions.
Mbala-Kingebeni P; Villabona-Arenas CJ; Vidal N; Likofata J; Nsio-Mbeta J; Makiala-Mandanda S; Mukadi D; Mukadi P; Kumakamba C; Djokolo B; Ayouba A; Delaporte E; Peeters M; Muyembe Tamfum JJ; Ahuka-Mundeke S
Clin Infect Dis; 2019 Jan; 68(2):330-333. PubMed ID: 29961823
[TBL] [Abstract][Full Text] [Related]
19. Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus.
Mire CE; Matassov D; Geisbert JB; Latham TE; Agans KN; Xu R; Ota-Setlik A; Egan MA; Fenton KA; Clarke DK; Eldridge JH; Geisbert TW
Nature; 2015 Apr; 520(7549):688-691. PubMed ID: 25853476
[TBL] [Abstract][Full Text] [Related]
20. Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.
Geisbert TW; Geisbert JB; Leung A; Daddario-DiCaprio KM; Hensley LE; Grolla A; Feldmann H
J Virol; 2009 Jul; 83(14):7296-304. PubMed ID: 19386702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
